Web Images Videos Maps News Shopping Gmail more »
Sign in 
Go to Google News Home 
  Advanced archive search
  Archive search help
 News Archives   News Articles - Timeline   Results 1 - 10 of about 591 for parkinson + two + compounds. (0.08 seconds) 
« View recent news results for parkinson two compounds
1990-99  Search other dates

… SLOWED BY VITAMIN E, PARKINSON'S DRUG STUDIES REPORT …
Pay-Per-View - Chicago Tribune - ProQuest Archiver - Apr 24, 1997
 A two-year study found that the two compounds, when given separately or in combination, decreased the loss of daily activities, including dressing, ...
Vitamin or Drug May Slow - Wall Street Journal... - Dow Jones & Company (Subscription)
Alzheimer's Study `Not a Major Breakthrough';... - Washington Post - ProQuest Archiver (Pay-Per-View)
Sacramento Bee - Knight Ridder/Tribune... - All 28 related - Related web pages

Amgen in Deal for Potential Nerve Disorder Treatments
New York Times - Aug 22, 1997
 ... Inc. to acquire the rights to a class of new compounds that could serve as the ... that distinction is a result of two drugs -- Epogen and Neupogen, ...
CALIFORNIA: News and Insight on Business in the... - Los Angeles Times - ProQuest Archiver (Pay-Per-View)
Biotech licensing deal for Guilford sets record - Washington Times - NewsBank ($2.95)
Wall Street Journal... - Wall Street Journal... - All 6 related - Related web pages

Washingtonpost.com: Tobacco Special Report
Washington Post - Nov 9, 1998
 ... broad range of ailments that includes Alzheimer's and Parkinson's diseases, ... Two compounds, known as RJR-2557 and RJR-1734, also trigger the brain's ...
STUDY CITES NICOTINE-BASED DRUGS FOR THEIR... - Buffalo News - NewsBank ($2.95)
All 8 related - Related web pages

The danger within
Forbes - Dec 13, 1999
 ... twice the number of Alzheimer's patients and seven times those with Parkinson's. ... In corporate labs two new compounds are in the works, ...
The Danger Within - Forbes
All 2 related - Related web pages

… NEWS; UPJOHN IN VENTURE ON NERVE SYSTEM COMPOUNDS
New York Times - Nov 21, 1992
 ... human clinical trials for treatment of Parkinson's disease and intermediate, ... The other two compounds are beginning Phase I clinical testing for ...
Related web pages

Amgen begins testing drug for Parkinson's; It contains compounds Hopki...
Pay-Per-View - The Sun - ProQuest Archiver - Aug 5, 1999
 The compounds are believed to play an important role in regenerating nerve cell branches. Amgen has been unusually quiet about the Parkinson's project. ...
Amgen Venture Tests New Drug - Wall Street Journal... - Dow Jones & Company (Subscription)
AMGEN, PARTNER TEST NERVE DRUG - Daily News of Los Angeles - NewsBank ($3.50)
All 3 related - Related web pages

Brain Chemical Offers Hope For Treating Nerve Disorders
Pay-Per-View - Washington Post - ProQuest Archiver - Jan 26, 1995
 Scientists who injected a nerve-nourishing compound into the brains of mice ... involved in Parkinson's disease, then measured those cells' survival two ...
All 10 related - Related web pages

Researchers Investigate (Horrors!) Nicotine's Potential Benefits
New York Times - Jan 14, 1997
 Dr. G. Kenneth Lloyd of Sibia Neurosciences Inc. in San Diego said his company was testing two nicotine-like compounds that separately targeted Parkinson's ...
Related web pages

Boosting the brain's disease-fighting power
Pay-Per-View - USA TODAY - ProQuest Archiver - Aug 5, 1992
 When the compounds link up with these cells, they enhance the cells' natural ... Next step: testing animals with Parkinson's and Alzheimer's-like symptoms. ...
All 5 related - Related web pages

Science: Brain diseases may be triggered by toxins in food
New Scientist - Jun 9, 1990
 This compound is a black-market drug and produces acute symptoms that resemble Parkinson's in people who inject it into their veins (see 'The intricate ...
Related web pages






Dates associated with search results are estimated and are determined automatically by a computer program.
 

Google Home - About Google - About News archive search

©2009 Google